The global pharmaceutical glass packing market is expected to grow at a CAGR of around 5.3% from 2020 to 2027 and expected to reach the market value of around US$ 33.2 Bn by 2027
Packaging is the process of providing protection, storage, appearance, identification, information convenience, and compliance for easy use of products, carriage, and display. Packaging provides a unique selling proposition, brand strategy differentiation and also assists in the separation of a company's goods from that of its rivals. Packing material is the immediate next important thing after completion of formulation to store the products till its use. Pharmaceutical packaging is an integral component of the industry's distribution mechanism for pharmaceutical goods and medications. Solids, semi-solids, liquids, and other pharmaceuticals can be packed with pharmaceutical glass packaging material depends on the requirement of the formulation.
Glass is made up of using sand, soda ash cullet, sodium carbonate and limestone. The composition is different for a variety of products it depends on the dosage forms. Glass is very sophisticated and attractive, they are resistant to strong acids and alkalis. It can be moulded into different forms according to requirements of the products. Glass is suitable for both moist heat and dry heat sterilization so that It can be used for variety of products. Glass packaging prevents the contamination and original properties of pharmaceutical products. Glass is the only material which is recognized by USFDA as safest material for primary packing. Amber color glass, transparent borosilicate glass, soda-lime glass are the most widely used glass in the pharmaceutical industry and chemical industry as well.
Rising awareness about the environment and eradication of plastic consumption in pharmaceutical formulations enhances the use of glass. Adoption of new technology in the recycling of the glass for future use would be a driving factor to push the growth of the global pharmaceutical glass packing market. Rising health awareness, protection for sensitive drugs and increasing demand for convenience in the highly competitive pharmaceutical packaging market necessitates brand enhancement/differentiation through the development of new packaging material and easy application of artworks on the surface of the glass is a driver for the pharmaceutical packaging industry. Upgrading to new packaging types such as child-resistant packaging (CRP), radiofrequency identification technology, and others with improved properties have led to the rapid growth of the market.
Complete use of glass for packing in the pharmaceutical sector led to increased cost of products and it would restrain the growth of the market. Lack of proper infrastructure unorganized healthcare system and regulations in emerging markets are restraints. In this advanced era, glass packing is increasingly being substituted with plastic in the pharmaceutical sector and it has features like flexibility, easy to transport, easy molding, cost-effectiveness, resistance and lightweight.
Segment Analysis by Region
The global pharmaceutical glass packaging market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Based on consumption North America accounted for a major share of the pharmaceutical glass packaging market and Europe is the second after North America. The glass bottles and syringe are widely utilized form of packaging in the U.S. and it also leads the pharmaceutical glass packaging market, in terms of consumption and development. Europe is the next biggest market for pharmaceutical glass packing in which Germany and U.K have a substantial effect on growth in the market. This would be attributed to the implementation of new guidelines by governments to control the transmission of infectious diseases and covid19 as well. In APAC India, china and japan are the leading countries contributing to the growth of the glass packing market. Increasing investment in the pharmaceutical industry and expansion of generic markets and R&D centers are expected to fuel the utilization of glass packing in the forthcoming years. The pharmaceutical glass packaging market in Middle East & Africa is likely to expand at a sluggish pace due to less presence of pharmaceutical companies and no investment in R&D.
Covid19 Impact on Global Pharmaceutical Glass Packing Market:
Many Industries across the globe were affected by covid19 pandemic but Pharmaceutical Industry is still remained same and has great positive impact in terms of sales and market share. The recent outbreak of COVID-19 has positively impacted the market growth due to the growing use of pharmaceutical glass packaging in the packaging of Vaccines, Biological drugs, immunity-boosting drugs. Many pharmaceutical glass packaging manufacturers were experienced high demand for COVID-19-related products. Hence, they are implementing novel technologies to automate their operations. Our research reports will help you better understand the current scenario of the market so that you can adopt the right strategy. Healthcare sector and pharmaceutical industry are the frontline elements to treat and eradicate the Covid19 pandemic. These sectors were excused from the restrictions of lockdowns due to their activities being essential for the community. The Pharmaceutical Glass packing industries were also excused from lockdown to provide sufficient packing materials as per requirements. As consumption of pharmaceutical products increased the demand for glass packing also increased.
Top pharmaceutical glass packing companies are engaging in strategic acquisitions such as new product launches, drug developments, R&D, agreements, and collaborations to gain market share. The competitive rivalry among existing competitors is high. Further, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand in the market. Major companies in the global pharmaceutical glass packaging market include Schott AG, Becton Dickinson, Gerresheimer AG, Nipro Group, SGD Pharma, Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group S.p.A., Bormioli Rocco Pharma, Ardagh Group, Piramal Glass, Sisecam Group, Stolzle-OberglasGmbh, Beatson Clark, and Arab Pharmaceutical Glass Co.
Nipro Group a leading global supplier of glass primary packaging for the pharmaceutical industry. The company has completed the acquisition of Piramida, a leading Croatian manufacturer of glass pharmaceutical packaging. Blue Sea Capital, a regional private equity fund, and NiproPharmaPackaging have closed the sale and transfer of full ownership stake in Piramida.
Stevanato Group on May 25th announced a licensing agreement with Corning Incorporated to offer a combined solution that will provide biopharmaceutical companies with improved levels of protection for injectable drugs while enabling smoother manufacturing operations.
A new product, Corning Valor® RTU Vials with SG EZ-fill® Technology, offers the industry the unique combination of Corning Valor® Glass vial attributes with SG EZ-fill® integration and packaging advantages.
Pharmaceutical Glass Packing Market Segment Analysis, 2021
The Global pharmaceutical glass packing market is segmented into Product, Drug type, Material type and Region. The Product is further bifurcated as Vials, Bottles, Ampoules, Cartridges & Syringes and other special products. The Drug type is further divided into Biologic, Branded and Generic. The material is further bifurcated into Type-I, Type-II and Type-III.
Market By Product
Cartridges and syringes
Other Special Products
Market By Drug type
Market By Material type
Type - I
Type - II
Type - III
Type - IV
The global Pharmaceutical Glass packing market in 2027 is expected to be above US$ 33.2 Bn.
The CAGR of the global Pharmaceutical Glass Packing market from 2021-2027 is 5.3%
Increased production of parenteral preparations, biological products due increased sales are the major drive for global pharmaceutical glass packing market
In Product segment Vials are growing at faster pace.
North America region is expected to grow faster.
Some of the players considered in the report scope are Schott AG, BD, Gerresheimer AG, Nipro Corp, Owens – Illinois, Berry Global, Inc, Catalent, Inc.
North America is expected to account for major revenue share in the global market.